JOE
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Accepted Preprint first posted online on 24 July 2008

Journal of Endocrinology 2008;199:69.

Journal of Endocrinology (2008) In press
DOI: 10.1677/JOE-08-0028
© 2008 Society for Endocrinology
This Article
Right arrow Accepted manuscript (PDF)
Right arrow All Versions of this Article:
JOE-08-0028v1
199/1/69    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Himpe, E.
Right arrow Articles by Kooijman, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Himpe, E.
Right arrow Articles by Kooijman, R.

RESEARCH

Insulin-like Growth Factor-I Delays Fas-mediated Apoptosis in Human Neutrophils through the Phosphatidylinositol-3 Kinase Pathway

Eddy Himpe, Celine Degaillier, Astrid Coppens and Ron Kooijman

E Himpe, FARC, VUB, Brussels, 1090, Belgium
C Degaillier, FARC, VUB, Jette, Belgium
A Coppens, FARC, VUB, Brussels, Belgium
R Kooijman, FARC, VUB, Jette, Belgium

Correspondence: Eddy Himpe, Email: eddy.himpe{at}vub.ac.be

Abstract

Apoptosis of human neutrophils is a crucial mechanism for the resolution of inflammation. We previously showed that insulin-like growth factor-I (IGF-I) delays spontaneous neutrophil apoptosis without influencing the secretion of cytokines by these cells. In the present study, we further addressed the role of IGF-I in regulating neutrophil survival in the presence of other factors present during inflammation, and the mechanism involved in delaying apoptosis. We show that IGF-I delays neutrophil apoptosis triggered by the agonistic anti-Fas antibody CH11 and that the effect of IGF-I is comparable in magnitude with those of the acknowledged anti-apoptotic cytokines interferon-{gamma} (IFN{gamma}) and granulocyte-macrophage colony-stimulating factor (GM-CSF). Furthermore, IGF-I exerted additional effects on cell survival in the presence of these cytokines. IGF-I did not affect Fas expression or activation by anti-Fas of caspase-8, but inhibited the depolarization of the mitochondrial membrane. Inhibitor studies indicate that the phosphatidylinositol-3 kinase (PI3K) pathway, but not the MEK-ERK pathway mediates the effects of IGF-I. However, in contrast to GM-CSF, IGF-I did not induce phosphorylation and translocation to the membrane of Akt, the canonical downstream target of PI3K. We therefore speculate that other downstream targets of PI3K are involved in the delaying neutrophil apoptosis by IGF-I, possibly through stabilization of the mitochondrial membrane.







HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the Society for Endocrinology.